It is worth mentioning that appropriate treatment in newly diagnosed HF patients significantly ameliorated their inflammatory status after 12 months by reducing several pro-inflammatory mediators, which included TNF-a, IL-6, IL-1, C-reactive protein (CRP), and Vascular cell adhesion protein 1 (VCAM-1) [97]. This evidence concerns the gene TNF and hydrops fetalis.